Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients' immune status against tetanus; and EBX molecular biology family, which includes a range of tests for identifying various pathogens responsible for infectious diseases and assessing the magnitude of the infection. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
| 25.65 | |
| 25.65 | |
| - | |
| 25.65 | |
| 25.65 | |
| 13.6-25.7 | |
| 259 M | |
| 41.371 | |
| 10 027 K | |
| 145 M | |
| -0.262 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Eurobio Scientific ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023 Strong growth in half-year core business revenues, up 37% Successful deployment of the Group's strategy: Share of...
Eurobio Scientific Capital reduction through cancellation of treasury shares Cancellation of 400,000 treasury shares, representing approximately 3.53% of the share capital Paris, July 11, 2023 –7...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
